Inositol phosphoglycan putative insulin mediator in human amniotic fluid

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 19, Issue 1, 2006, Pages 9-12

  Scioscia, Marco ^a,b   Vimercati, Antonella ^b   Selvaggi, Luigi E ^b   Rodeck, Charles H ^a   Rademacher, Thomas W ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Amniotic fluid; Fetal growth; Inositol phosphoglycan; Insulin second messenger

Indexed keywords

INOSITOL DERIVATIVE; INOSITOL PHOSPHOGLYCAN; INSULIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AMNIOCENTESIS; AMNION FLUID; AMNION FLUID ANALYSIS; ANALYTIC METHOD; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS GROWTH; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MEDIATOR; PREGNANT WOMAN; PRIORITY JOURNAL; URINE;

ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INOSITOL PHOSPHATES; POLYSACCHARIDES; PREGNANCY; PROSPECTIVE STUDIES;

EID: 33644610625     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050500362321     Document Type: Article

References (20)

1. Fowden AL, Forhead AJ. Endocrine mechanisms of intrauterine programming. Reproduction 2004;127:515-526.
2. White MF. The IRS-signalling system: A network of docking proteins that mediate insulin action. Mol Cell Biochem 1998;182:3-11.
3. Fowden AL. The insulin-like growth factors and feto-placental growth. Placenta 2003;24:803-812.
4. Liberatori S, Bini L, De Felice C, Magi B, Marzocchi B, Raggiaschi R, Frutiger S, Sanchez JC, Wilkins MR, Hughes G, et al. A two-dimensional protein map of human amniotic fluid at 17 weeks' gestation. Electrophoresis 1997;18:2816-2822.
5. Stralfors P. Insulin second messengers. Bioessays 1997;19:327-335.
6. Frick W, Bauer A, Bauer J, Wied S, Muller G. Structure - activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action. Biochemistry 1998;37:13421-13436.
7. Kunjara S, Greenbaum AL, Wang DY, Caro HN, McLean P, Redman CW, Rademacher TW. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: Evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Mol Genet Metab 2000;69:144-158.
8. Paine MA, Scioscia M, Gumaa KA, Rodeck CH, Rademacher TW. IPG-P in serum and amniotic fluid in active preeclampsia. J Reprod Immunol 2005;in press.
9. Paine MA, Rodeck CH, Williams PJ, Rademacher TW. Possible involvement of inositol phosphoglycan-P in human parturition. J Reprod Immunol 2003;59:267-275.
10. Kunjara S, Wang DY, Greenbaum AL, McLean P, Kurtz A, Rademacher TW. Inositol phosphoglycans in diabetes and obesity: Urinary levels of IPG A-type and IPG P-type, and relationship to pathophysiological changes. Mol Genet Metab 1999;68:488-502.
11. Varela-Nieto I, Leon Y, Caro HN. Cell signalling by inositol phosphoglycans from different species. Comp Biochem Physiol B Biochem Mol Biol 1996;115:223-241.
12. Suzuki S, Sugawara K, Satoh Y, Toyota T. Insulin stimulates the generation of two putative insulin mediators, inositolglycan and diacylglycerol in BC3H-1 myocytes. J Biol Chem 1991;266:8115-8121.
13. Sleight S, Wilson BA, Heimark DB, Larner J. G(q/11) is involved in insulin-stimulated inositol phosphoglycan putative mediator generation in rat liver membranes: Co-localization of G(q/11) with the insulin receptor in membrane vesicles. Biochem Biophys Res Commun 2002;295:561-569.
14. Linton EA, Rodriguez-Linares B, Rashid-Doubell F, Ferguson DJ, Redman CW. Caveolae and caveolin-1 in human term villous trophoblast. Placenta 2003;24:745-757.
15. Deborde S, Schofield JN, Rademacher TW. Placental GPI-PLD is of maternal origin and its GPI substrate is absent from placentae of pregnancies associated with pre-eclampsia. J Reprod Immunol 2003;59:277-294.
16. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-799.
17. Kanaka-Gantenbein C, Mastorakos G, Chrousos GP. Endocrine-related causes and consequences of intrauterine growth retardation. Ann N Y Acad Sci 2003;997:150-157.
18. Barker DJ. In utero programming of chronic disease. Clin Sci (Lond) 1998;95:115-128.
19. Laviola L, Perrini S, Belsanti G, Natalicchio A, Montrone C, Leonardini A, Vimercati A, Scioscia M, Selvaggi L, Giorgino R, Greco P, et al. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology 2005;146:1498-1505.
20. Larner J. D-Chiro-inositol in insulin action and insulin resistance - old-fashioned biochemistry still at work. IUBMB Life 2001;51:139-148.